Skip to main content
logo
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.400
-0.100 (-2.22%)
At close: Mar 17, 2026, 4:00 PM EDT
4.400
0.00 (0.00%)
After-hours: Mar 17, 2026, 4:10 PM EDT

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1031219610712-
Market Cap Growth
-12.75%26.83%-10.31%769.77%--
Enterprise Value
59.6774.657.3974.1228.10
Last Close Price
4.405.805.737.414.74-
PE Ratio
--4.57-5.85-9.38-1.00-
PS Ratio
13.4015.2826.9417.78--
PB Ratio
2.192.822.423.00-1.46-
P/TBV Ratio
1.712.262.212.11-1.46-
P/FCF Ratio
--11.31-9.30-9.54-1.70-
P/OCF Ratio
--11.31-9.30-9.54-1.70-
EV/Sales Ratio
7.519.3916.1512.35--
EV/EBITDA Ratio
--3.31-3.33-9.41-2.87-
EV/EBIT Ratio
--3.31-3.33-9.38-2.86-
EV/FCF Ratio
--6.95-5.58-6.62-3.88-
Debt / Equity Ratio
-000-1.540
Debt / EBITDA Ratio
-----1.32-
Debt / FCF Ratio
-----1.79-
Net Debt / Equity Ratio
-1.09-1.09-0.97-0.92-0.84-1.19
Net Debt / EBITDA Ratio
2.082.082.234.14-0.720.89
Net Debt / FCF Ratio
4.364.363.732.92-0.971.07
Asset Turnover
0.170.170.080.2400
Quick Ratio
7.977.9710.027.941.553.78
Current Ratio
8.508.5011.598.151.883.99
Return on Equity (ROE)
-51.39%-51.39%-39.57%-58.64%515.59%-134.25%
Return on Assets (ROA)
-47.85%-47.85%-38.44%-35.00%-148.80%-101.63%
Return on Invested Capital (ROIC)
-3039.23%-3039.23%-436.56%-552.70%953.44%699.30%
Return on Capital Employed (ROCE)
-53.32%-53.32%-44.96%-38.76%-238.86%-133.66%
Earnings Yield
-19.93%-21.90%-17.10%-10.66%-99.83%-
FCF Yield
-10.08%-8.84%-10.75%-10.48%-58.99%-
Buyback Yield / Dilution
-16.79%-16.79%-16.87%-36.00%-0.00%-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q